SYS · ONLINEPASS · 63.0%
Open Assay
Independent Testing / Est. 2026
BATCH04·26·B
PASS63.0%
N27

Glossary

Phase 3 trial

Pivotal efficacy study for regulatory approval. Hundreds to thousands of participants across multiple sites. Used as basis for FDA approval.